期刊
CURRENT PHARMACEUTICAL BIOTECHNOLOGY
卷 20, 期 13, 页码 1108-1121出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1389201020666190809112704
关键词
Immunotherapy; monoclonal antibodies; viral diseases; treatment; emerging viruses; immunotherapeutics
The epidemiological impact of viral diseases, combined with the emergence and re-emergence of some viruses, and the difficulties in identifying effective therapies, have encouraged several studies to develop new therapeutic strategies for viral infections. In this context, the use of immunotherapy for the treatment of viral diseases is increasing. One of the strategies of immunotherapy is the use of antibodies, particularly the monoclonal antibodies (mAbs) and multi-specific antibodies, which bind directly to the viral antigen and bring about activation of the immune system. With current advancements in science and technology, several such antibodies are being tested, and some are already approved and are undergoing clinical trials. The present work aims to review the status of mAb development for the treatment of viral diseases.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据